[1]
|
C. Stocker, J. T. Ihsak, K.G., “Hepatoblastoma,” In: K. Okuda and K. G. Ishak, Eds., Neoplasms of the Liver, Springer-Verlag, Inc., New York, 1987, pp. 127-136.
|
[2]
|
D. C. Aronson, J. M. Schnater, C. R. Staalman, G. J. Weverling, J. Plaschkes, G. Perilongo, J. Brown, A. Phillips, et al., “Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study,” Journal of Clinical Oncology, Vol. 23, No. 6, 2005, pp. 1245-1252.
doi:10.1200/JCO.2005.07.145
|
[3]
|
G. Perilongo, R. Maibach, E. Shafford, L. Brugieres, P. Brock, B. Morland, et al., “Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma,” New England Journal of Medicine, Vol. 22, No. 361, 2009, pp. 1662-1670. doi:10.1056/NEJMoa0810613
|
[4]
|
S. B. Moon, H. B. Shin, J. M. Seo and S. K. Lee, “Hepatoblastoma: 15-Year Experience and Role of Surgical Treatment,” Journal of Korean Surgical Society, Vol. 81, No. 2, 2011, pp. 134-140. doi:10.4174/jkss.2011.81.2.134
|
[5]
|
J. B. Otte and R. Meyers, “PLUTO First Report,” Pediatric Transplantation, Vol. 14, No. 7, 2012, pp. 830-835.
doi:10.1111/j.1399-3046.2010.01395.x
|
[6]
|
S. Barrena, F. Hernandez, M. Miguel, C. A. de la Torre, A. M. Moreno, J. L. Encinas, et al., “High-Risk Hepatoblastoma: Results in a Pediatric Liver Transplantation Center,” European Journal of Pediatric Surgery, Vol. 21, No. 1, 2011, pp. 18-20. doi:10.1055/s-0030-1262798
|
[7]
|
J. Ninane, G. Perilongo, J. P. Stalens, M. Guglielmi, J. B. Otte and A. Mancini, “Effectiveness and Toxicity of Cisplatin and Doxorubisin (PLADO) in Childhood Hepatoblastoma and Hepatocellular Carcinoma: A SIOP Pilot Study,” Medical and Pediatric Oncology, Vol. 19, No. 3, 1991, pp. 199-203. doi:10.1002/mpo.2950190310
|
[8]
|
I. Penn, “Hepatic Transplantation for Primary and Metastatic Cancers of the Liver,” Surgery, Vol. 110, No. 4, 1991, pp. 726-735.
|
[9]
|
J. B. Otte, J. Pritchard, D. C. Aronson, J. Brown, P. Czauderna, R. Maibach, et al., “Liver Transplantation for Hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) Study SIOPEL-1 and Review of the World Experience,” Pediatric Blood Cancer, Vol. 42, No. 1, 2004, pp. 74-83. doi:10.1002/pbc.10376
|
[10]
|
J. B. Otte, J. de Ville de Goyet and R. Reding, “Liver Transplantation for Hepatoblastoma: Indications and Contraindications in the Modern Era,” Pediatric Transplantation, Vol. 9, No. 5, 2005, pp. 557-565.
doi:10.1111/j.1399-3046.2005.00354.x
|
[11]
|
J. Brown, G. Perlingo, E. Shafford, J. Keeling, J. Pritchard, P. Brock, et al., “Pretreatment Prognostic Factors for Children with Hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP). Study SIOPEL 1,” European Journal of Cancer, Vol. 36, No. 11, 2000, pp. 1418-1425. doi:10.1016/S0959-8049(00)00074-5
|
[12]
|
T. B. Lautz, T. Ben-Ami, N. Tantemsapya, Y. Gosiengfiao and R. A. Superina, “Successful Nontransplant Resection of POST-TEXT III and IV Hepatoblastoma,” Cancer, Vol. 117, No. 9, 2011, pp. 1976-1983.
doi:10.1002/cncr.25722
|
[13]
|
T. Hishiki, T. Matsunaga, F. Sasaki, M. Yano, K. Ida, H. Horie, et al., “Outcome of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor (JPLT) Protocol-2: Report from the JPLT,” Pediatric Surgery International, Vol. 27, No. 1, 2011, pp. 1-8.
doi:10.1007/s00383-010-2708-0
|
[14]
|
K. Urata, S. Kawasaki, H. Matsunami, Y. Hashikura, T. Ikegami, S. Ishizone, et al., “Calculation of Child and Adult Standard Liver Volume for Liver Transplantation,” Hepatology, Vol. 21, No. 5, 1995, pp. 1317-1321.
doi:10.1002/hep.1840210515
|
[15]
|
A. P. Pimpalwar, K. Sharif, P. Ramani, M. Stevens, R. Grundy, B. Moriand, et al., “Strategy for Hepatoblastoma Management: Transplant versus Nontransplant Surgery,” Journal of Pediatric Surgery, Vol. 37, No. 2, 2002, pp. 240-245. doi:10.1053/jpsu.2002.30264
|
[16]
|
G. M. Tiao, N. Bobey, S. Allen, N. Nieves, M. Alonso, J. Bucuvalas, et al., “The Current Management of Hepatoblastoma: A Combination of Chemotherapy, Conventional Resection, and Liver Transplantation,” Journal of Pediatrics, Vol. 146, No. 2, 2005, pp. 204-211.
doi:10.1016/j.jpeds.2004.09.011
|
[17]
|
V. D. Schweinitz, H. Hecker, G. Schmidt-von-Amdt and D. Harms, “Prognostic Factors and Staging Systems in Childhood Hepatoblastoma,” International Journal of Cancer, Vol. 74, No. 6, 1997, pp. 593-599.
doi:10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P
|
[18]
|
Y. Kita, Y. Ishida and K. Yanaga, “Evolution of Live Donor Liver Transplantation in Japan: A Historical Perspective,” Hungarian Medical Journal, Vol. 1, No. 2, 2007, pp. 157-163. doi:10.1556/HMJ.1.2007.2.3
|
[19]
|
W. Faraj, F. Dar, G. Marangoni, A. Bartlett, H. V. Melendez, D. Hadzic, et al., “Liver Transplantation for Hepatoblastoma,” Liver Transplantation, Vol. 14, No. 11, 2008, pp. 1614-1619. doi:10.1002/lt.21586
|
[20]
|
A. J. Millar, P. Harley, D. Khan, W. Spearman, S. Andronikou and H. Rode, “Extended Hepatic Resection with Transplantation Back-Up for An “Unresectable” Tumor,” Pediatric Surgery International, Vol. 17, No. 5-6, 2001, pp. 378-381. doi:10.1007/s003830000531
|
[21]
|
F. Guerin, F. Gauthier, H. Martelli, M. Fabre, C. Baujard, S. Franchi, et al., “Outcome of Central Hepatectomy for Hepatoblastoma,” Journal of Pediatric Surgery, Vol. 45, No. 3, 2010, pp. 555-563.
doi:10.1016/j.jpedsurg.2009.09.025
|
[22]
|
M. Browne, D. Sher, D. Grant, E. Deluca, E. Alonso, P. F. Whitington, et al., “Survival after Liver Transplantation for Hepatoblastoma: A 2-Center Experience,” Journal of Pediatric Surgery, Vol. 43, No. 11, 2008, pp. 1973-1981.
doi:10.1016/j.jpedsurg.2008.05.031
|
[23]
|
J. Zsiros, R. Maibach, E. Shafford, L. Brugieres, P. Brock, P. Czaudema, et al., “Successful Treatment of Childhood High-Risk Hepatoblastoma with Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of SIOPEL-3HR Study,” Journal of Clinical Oncology, Vol. 28, No. 15, 2010, pp. 2584-2590.
doi:10.1200/JCO.2009.22.4857
|
[24]
|
D. Von Schweinitz, “Hepatoblastoma: Recent Developments in Research and Treatment,” Seminars in Pediatric Surgery, Vol. 21, No. 1, 2012, pp. 21-30.
|
[25]
|
M. Kasahara, M. Ueda, H. Haga, H. Hiramatsu, M. Kobayashi, S. Adachi, et al., “Living-Donor Liver Transplantation for Hepatoblastoma,” American Journal of Transplantation, Vol. 5, No. 9, 2005, pp. 2229-2235.
doi:10.1111/j.1600-6143.2005.01003.x
|